---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-272490"
form_type: "8-K"
ticker: null
cik: "0001538210"
company_name: "NexImmune, Inc."
filed_at: "2022-10-28T23:59:59+00:00"
generated_at: "2026-06-22T22:36:33.104442+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NexImmune receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Deficiency letter received Oct 25, 2022; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 days, until April 24, 2023, to regain compliance with Minimum Bid Price Requirement.
- If non-compliant, may transfer listing to Nasdaq Capital Market or face delisting.
- Company may consider options including reverse stock split to cure deficiency.
- No immediate effect on listing; stock continues trading on Nasdaq under symbol NEXI.

## SEC filing metadata
- accession: 0001193125-22-272490
- form_type: 8-K
- cik: 0001538210
- company_name: NexImmune, Inc.
- filed_at: 2022-10-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1538210/000119312522272490/0001193125-22-272490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1538210/000119312522272490/d405955d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-272490
- JSON: https://secwatch.observer/filing/0001193125-22-272490.json
- Plain text: https://secwatch.observer/filing/0001193125-22-272490.txt

## Key facts
- Listing & Compliance Notices
  NexImmune, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: October 25, 2022, NexImmune, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock, and it
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312522272490/0001193125-22-272490-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.